4th Quarter - Report

UPSTREAM CONSULTING for MELINTA THERAPEUTICS INC (FKA RIB-X PHARMACEUTICALS INC )

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to Health Care

LobbyistCovered position, as disclosed
MICHAEL J EGING Principal
JOHN M. HADDOW Principal

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.